Patent ID: 7432296

Claim:
A pharmaceutical formulation comprising at least one substituted 2-arylaminoacetic acid compound corresponding to formula I, wherein R 1 denotes a phenyl residue which is identically substituted in the 3,5-position, wherein the substituents are selected from the group consisting of F, Cl, Br, I, OH, SH, unsubstituted C 1-6 alkyl, unsubstituted C 1-6 alkoxy, C 1-6 perfluoroalkyl, C 1-6 perfluoroalkoxy, unsubstituted C 1-6 alkylsulfanyl, C 1-6 perfluoroalkylsulfanyl, unsubstituted phenylsulfanyl, unsubstituted cyclopentyl and unsubstituted cyclohexyl, R 2 denotes a residue which is selected from the group consisting of dibenzofuran-4-yl, dibenzothiophen-4-yl, phenoxathiin-4-yl, thianthren-1-yl, 2-methylsulfanylphenyl, 3-methylsulfanylphenyl and 4-methylsulfanylphenyl, or an acid, base or a salt thereof, and a pharmaceutically acceptable adjuvant.